Caplin Point Laboratories has informed that the meeting of the Board of Directors of the Company is scheduled on 18/01/2019, to consider and approve the Investment by a global financial investor with strong healthcare experience in the Wholly Owned Subsidiary Company, Caplin Steriles. Further, the trading window continues to remain closed until January 20, 2019 for Promoters, Directors, other Connected Persons and Employees of the Company as per the Company’s Code of Conduct to regulate, monitor and report trading by insiders adopted by the Board pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.
